Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
ANTX holding history
AN2 Therapeutics, Inc. in every 13F filed by Pfizer Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −715,295−100.0% | Sold out | Holders |
| Q4 2025 | 715,295 | $815.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 715,295 | $908.4K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 715,295 | $758.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 715,295 | $972.8K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 715,295 | $987.1K | <0.1% | – | No prior filing | Holders |